Severe symptomatic hypocalcemia in a patient with RDEB treated with intravenous zoledronic acid.
Perman
Marissa J
MJ
Lucky
Anne W
AW
Heubi
James E
JE
Azizkhan
Richard G
RG
D000293:Adolescent; D050071:Bone Density Conservation Agents / Q000009:adverse effects*; D001851:Bone Diseases, Metabolic / Q000188:drug therapy* / Q000209:etiology; D004164:Diphosphonates / Q000009:adverse effects*; D016108:Epidermolysis Bullosa Dystrophica / Q000150:complications*; D006801:Humans; D006996:Hypocalcemia / Q000139:chemically induced*; D007093:Imidazoles / Q000009:adverse effects*; D008297:Male; D000077211:Zoledronic Acid
D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D007093:Imidazoles; D000077211:Zoledronic Acid